Subscribe To
apellis pharmaceuticals reports third quarter 2023 financial results
Generated total revenues of $110.4 million in the third quarter, including $75.3 million for SYFOVRE® (pegcetacoplan injection) and $23.9 million for...
November 1, 2023, 11:05 am
apecoin and akita inu: apecoin is hovering around 1,300
apeCoin and Akita Inu: apeCoin is hovering around 1,300 ...
November 1, 2023, 10:54 am
Why is aldeyra therapeutics (aldx) stock up 40% today?
Aldeyra Therapeutics (NASDAQ: ALDX ) stock is on the rise Wednesday after entering into an exclusive op...
November 1, 2023, 10:34 am
Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting
– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...
November 1, 2023, 10:30 am
Disney+ rolls out new ad-supported options, hikes existing plan by £3 a month
The Walt Disney Company (NYSE:DIS) has officially launched its new ad-supported Disney+ streaming subscription tier in the UK, offering viewers a more...
November 1, 2023, 10:23 am
apellis pharmaceuticals, inc. (apls) reports q3 loss, tops revenue estimates
apellis Pharmaceuticals, Inc. (APLS) came out with a quarterly loss of $1.17 per share versus the Zacks...
November 1, 2023, 9:46 am
Anaptys announces participation in november investor conferences
SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...
November 1, 2023, 9:15 am
Scapegoat or guilty? connolly's $150 million battle against deutsche bank
US District Judge Jesse Furman has denied Deutsche Bank's motion to dismiss a $150 million lawsuit filed by Matthew Connolly, a former trader at the f...
November 1, 2023, 9:11 am
The influence of central banks on forex trading
Central bank interest rates play a crucial role in shaping the forex market landscape. Discover the piv...
November 1, 2023, 8:54 am
Quantumscape stock: bull vs. bear
After soaring on their debut, shares of the EV battery maker have slumped. The battery's progress toward commercialization is an encouraging sign....
November 1, 2023, 8:45 am
Cardiol therapeutics reaches new milestone in phase ii study for recurrent pericarditis
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced it has successfully enrolled over 50% of the tar...
November 1, 2023, 8:41 am
Zymeworks announces participation in upcoming investor conferences
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...
November 1, 2023, 8:30 am
Verve therapeutics (verv) surges 28.0%: is this an indication of further gains?
Verve Therapeutics (VERV) witnessed a jump in share price last session on above-average trading volume....
November 1, 2023, 8:16 am
United therapeutics (uthr) q3 earnings and revenues top estimates
United Therapeutics (UTHR) came out with quarterly earnings of $5.38 per share, beating the Zacks Conse...
November 1, 2023, 8:16 am
Siteone landscape (site) q3 earnings miss estimates
SiteOne Landscape (SITE) came out with quarterly earnings of $1.25 per share, missing the Zacks Consens...
November 1, 2023, 8:16 am
Outlook therapeutics® to present at guggenheim's 5th annual inflammation, neurology & immunology (ini) conference
Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET...
November 1, 2023, 8:05 am
Aptevo to present at bio-europe conference
SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage ...
November 1, 2023, 7:45 am
Atea pharmaceuticals to host third quarter 2023 financial results conference call on november 8, 2023
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged i...
November 1, 2023, 7:00 am
Why qs stock may be approaching the ‘buy zone'
I have long taken a bearish view on QuantumScape (NYSE: QS ) stock. However, while I'm not a fan at $10...
November 1, 2023, 6:35 am
Missed out on nvidia's magnificent rally? buy this incredibly cheap artificial intelligence (ai) stock before it goes parabolic.
Nvidia stock's rapid rise in the past year has made it expensive, but there is another high-flying stock that's available at a much che...
November 1, 2023, 6:05 am